Acuitive Technologies Gains FDA Clearance for CITRESPLINE and CITRELOCK Ligament Reconstruction

Acuitive Technologies CITRESPLINE and CITRELOCK Ligament Reconstruction

Acuitive Technologies received FDA clearance to market CITRESPLINE™ and CITRELOCK™ Ligament Reconstruction Devices, manufactured with patented CITREGEN™ bioresorbable synthetic polymer.

CITREGEN releases molecules that support bone formation throughout its bioresorption process, leaving behind a biomimetic ceramic structure to be...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.

JV

Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.



Contact Us

0